Safety and Efficacy of a New Treatment in Vitrectomized Subjects With Diabetic Macular Edema.

Trial Profile

Safety and Efficacy of a New Treatment in Vitrectomized Subjects With Diabetic Macular Edema.

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Oct 2014

At a glance

  • Drugs Dexamethasone (Primary)
  • Indications Diabetic macular oedema
  • Focus Therapeutic Use
  • Sponsors Allergan
  • Most Recent Events

    • 14 Sep 2010 Actual end date (Dec 2009) added as reported by ClinicalTrials.gov.
    • 14 Sep 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 19 Feb 2009 Additional location identified as reported by ClinicalTrials.gov, last updated 19 Feb 2009
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top